Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

Sue C. Bodine; Trevor N. Stitt; Michael Gonzalez; William O. Kline; Gretchen L. Stover; Roy Bauerlein; Elizabeth Zlotchenko; Angus G. Scrimgeour; John C. Lawrence; David J. Glass; George D. Yancopoulos

doi:10.1038/ncb1101-1014

Keywords

PI3K/AKT/mTOR pathwayMuscle hypertrophyProtein kinase BCalcineurinSkeletal muscleMuscle atrophyNFATInternal medicineRPTOREndocrinologyBiologyAtrophyCell biologySignal transductionMedicineTransplantation

Affiliated Institutions

Related Publications

Targeting PI3K/Akt signal transduction for cancer therapy

Yan He , Miao Sun , Guo Geng Zhang +4 more

The phosphatidylinositol 3-kinase (PI3K)/Akt pathway plays a crucial role in various cellular processes and is aberrantly activated in cancers, contributing to the occurrence an...

2021 Signal Transduction and Targeted Therapy 1437 citations

Renin‐Angiotensin System: An Old Player with Novel Functions in Skeletal Muscle

Claudio Cabello‐Verrugio , María Gabriela Morales , Juan Carlos Aristizábal Rivera +2 more

Abstract Skeletal muscle is a tissue that shows the most plasticity in the body; it can change in response to physiological and pathological stimuli. Among the diseases that aff...

2015 Medicinal Research Reviews 154 citations

Changes in skeletal muscle with aging: effects of exercise training.

Marc A. Rogers , William J. Evans

There is an approximate 30% decline in muscle strength and a 40% reduction in muscle area between the second and seventh decades of life. Thus, the loss of muscle mass with agin...

1993 PubMed 397 citations

The PI3K/AKT pathway in obesity and type 2 diabetes

Xingjun Huang , Guihua Liu , Jiao Guo +1 more

Obesity and type 2 diabetes mellitus are complicated metabolic diseases that affect multiple organs and are characterized by hyperglycaemia. Currently, stable and effective trea...

2018 International Journal of Biological S... 1475 citations

Phosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of Rapamycin

Gregory J. Brunn , Christine C. Hudson , Aleksandar Sekulić +5 more

The immunosuppressant rapamycin interferes with G 1 -phase progression in lymphoid and other cell types by inhibiting the function of the mammalian target of rapamycin (mTOR). m...

1997 Science 956 citations

Publication Info

Year: 2001
Type: article
Volume: 3
Issue: 11
Pages: 1014-1019
Citations: 2653
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2653

OpenAlex

Cite This

APA Style

                            
                                
                                    Sue C. Bodine, 
                                
                                    Trevor N. Stitt, 
                                
                                    Michael Gonzalez
                                
                                et al.
                            
                            (2001). 
                            Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. 
                            Nature Cell Biology
                            , 3
                            (11)
                            , 1014-1019.
                            https://doi.org/10.1038/ncb1101-1014
                        

Identifiers

DOI: 10.1038/ncb1101-1014